: One of the best performers of 2017, climbing from $1.01 to over $5.25 following successful clinical trials. Investment Perspective for 2017
: Priced under $10 in late 2017, it saw a 40% year-to-date gain and was expected to significantly improve EPS. stocks under 10 dollars to buy 2017
: Trading as low as $1.54 in early 2017; it was a market leader in solar microinverters but faced market pressure. : One of the best performers of 2017, climbing from $1